Literature DB >> 10528093

Development of a rectal nicotine delivery system for the treatment of ulcerative colitis.

A K Dash1, Z Gong, D W Miller, H Huai-Yan, J Laforet.   

Abstract

The aims of this investigation were: i. to develop a rectal nicotine delivery system with bioadhesives for the treatment of ulcerative colitis and ii. to evaluate nicotine transport and cytotoxicity of the delivery system using Caco-2 cell culture systems. Rectal nicotine suppository formulations were prepared in semi-synthetic glyceride bases (Suppocire AM and AI, Gattefosse Inc.) by fusion method. The in vitro release of nicotine was carried out in modified USP dissolution apparatus 1. Differential scanning calorimetry (DSC) and powder X-ray diffraction were used to study the polymorphic changes if any in the formulations. An LC method was used for the assay of nicotine. The effect of bioadhesives (glyceryl monooleate (GMO), and Carbopol) on the nicotine flux was evaluated using Caco-2 cell permeability studies and Caco-2 cell viability was determined using the MTT toxicity assay. In vitro release studies indicated that the low melting AI base was superior to that of the AM base. Presence of GMO in the formulation enhanced the release of nicotine whereas Carbopol showed an opposite effect. The enhanced release of nicotine in the presence of GMO was found to be partly due to the melting point lowering effect of this compound. Caco-2 cell absorption studies showed that there was a decrease in the flux of nicotine in the presence of both the bioadhesives. The flux of the fluorescein marker which is used to study the integrity of the cell monolayers was found to be slightly higher only in the presence of 10% (w/w) Carbopol. Nicotine, Carbopol, and GMO do not have any cytotoxic effect on these cell monolayers within the concentration range used in the formulations. Rectal nicotine formulations containing bioadhesives were developed and characterized. Both in vitro release and cell culture studies have indicated that one can manipulate the nicotine release from these rectal delivery systems by incorporation of various bioadhesives or the use of different bases in the formulation. Nicotine concentration below 2% (w/v) and bioadhesive concentration below 10% (w/w) do not have any cytotoxic effect on Caco-2 cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528093     DOI: 10.1016/s0378-5173(99)00221-5

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Study on of bioadhesive property of carbomer 934 by a gamma camera in vivo.

Authors:  Jie Fu; Xun Sun; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  A mucoadhesive in situ gel delivery system for paclitaxel.

Authors:  Saurabh Jauhari; Alekha K Dash
Journal:  AAPS PharmSciTech       Date:  2006-06-02       Impact factor: 3.246

3.  Evaluation of an acetic acid ester of monoglyceride as a suppository base with unique properties.

Authors:  A K Dash; G C Cudworth
Journal:  AAPS PharmSciTech       Date:  2001-07-17       Impact factor: 3.246

4.  Surfactants modify the release from tablets made of hydrophobically modified poly (acrylic acid).

Authors:  Patrik Knöös; Sebla Onder; Lina Pedersen; Lennart Piculell; Stefan Ulvenlund; Marie Wahlgren
Journal:  Results Pharma Sci       Date:  2013-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.